Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma

« Previous Next »Surgery
Volume 147, Issue 3 , Pages 424-431, March 2010

Yorihisa Orita, MD, PhD
- Department of Otolaryngology Head and Neck Surgery, Okayama Saiseikai General Hospital, Okayama, Japan
- Reprint requests: Yorihisa Orita, MD, PhD, Department of Otolaryngology Head and Neck Surgery, Okayama Saiseikai General Hospital, 1-17-18, Ifuku-Cho, Okayama 700-8511, Japan.
Iwao Sugitani, MD, PhD
- Division of Head and Neck, Cancer Institute Hospital, Tokyo, Japan
Masaaki Matsuura, PhD
- Department of Cancer Genomics, Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
Masaru Ushijima, MSc
- Department of Bioinformatics of Genome Center, Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
Kiyoaki Tsukahara, MD, PhD
- Department of Otolaryngology, Tokyo Medical University, Tokyo, Japan
Yoshihide Fujimoto, MD, PhD
- Division of Head and Neck, Cancer Institute Hospital, Tokyo, Japan
Kazuyoshi Kawabata, MD, PhD
- Division of Head and Neck, Cancer Institute Hospital, Tokyo, Japan